Published in Ophthalmology on October 01, 2001
Ocular Hypertension Treatment Study (OHTS) (OHTS) | NCT00000125
Biomechanics and wound healing in the cornea. Exp Eye Res (2006) 2.79
Reduction in intraocular pressure after cataract extraction: the Ocular Hypertension Treatment Study. Ophthalmology (2012) 2.35
Mechanical environment of the optic nerve head in glaucoma. Optom Vis Sci (2008) 1.74
Intraobserver and interobserver reproducibility in the evaluation of ultrasonic pachymetry measurements of central corneal thickness. Br J Ophthalmol (2004) 1.52
The medical and surgical treatment of glaucoma. Dtsch Arztebl Int (2009) 1.44
Current concepts on primary open-angle glaucoma genetics: a contribution to disease pathophysiology and future treatment. Eye (Lond) (2011) 1.24
Associations with intraocular pressure in Latinos: the Los Angeles Latino Eye Study. Am J Ophthalmol (2008) 1.23
Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma. Ophthalmology (2011) 1.23
The path to open-angle glaucoma gene discovery: endophenotypic status of intraocular pressure, cup-to-disc ratio, and central corneal thickness. Invest Ophthalmol Vis Sci (2010) 1.18
Genetic dependence of central corneal thickness among inbred strains of mice. Invest Ophthalmol Vis Sci (2009) 1.12
Relationship of Fuchs endothelial corneal dystrophy severity to central corneal thickness. Arch Ophthalmol (2012) 1.08
Microphthalmia, persistent hyperplastic hyaloid vasculature and lens anomalies following overexpression of VEGF-A188 from the alphaA-crystallin promoter. Mol Vis (2007) 1.08
Rates of retinal nerve fiber layer thinning in glaucoma suspect eyes. Ophthalmology (2014) 1.07
Central corneal thickness in adult Chinese. Association with ocular and general parameters. The Beijing Eye Study. Graefes Arch Clin Exp Ophthalmol (2008) 1.05
Central corneal thickness in children. Arch Ophthalmol (2011) 1.05
Intra-examiner repeatability and agreement of corneal pachymetry map measurement by time-domain and Fourier-domain optical coherence tomography. Graefes Arch Clin Exp Ophthalmol (2010) 1.01
Accuracy of dynamic contour tonometry compared with applanation tonometry in human cadaver eyes of different hydration states. Graefes Arch Clin Exp Ophthalmol (2004) 1.01
Color Doppler imaging in ocular hypertension and open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol (2003) 0.98
[Ocular pulse amplitude: a new biometrical parameter for the diagnose of glaucoma?]. Ophthalmologe (2007) 0.98
Comparison of Goldmann and Pascal tonometry in relation to corneal hysteresis and central corneal thickness in nonglaucomatous eyes. Clin Ophthalmol (2011) 0.94
Quantitative trait loci associated with murine central corneal thickness. Physiol Genomics (2010) 0.93
Comparison of corneal biomechanical properties between healthy blacks and whites using the Ocular Response Analyzer. Am J Ophthalmol (2010) 0.93
[Dynamic contour tonometry]. Ophthalmologe (2006) 0.92
Distribution of central corneal thickness and its association with ocular parameters in a large central European cohort: the Gutenberg health study. PLoS One (2013) 0.92
Goldmann applanation tonometry compared with corneal-compensated intraocular pressure in the evaluation of primary open-angle Glaucoma. BMC Ophthalmol (2012) 0.91
Central corneal thickness in Northwestern American Indians/Alaskan Natives and comparison with White and African-American persons. Am J Ophthalmol (2008) 0.89
Central corneal thickness in subjects with glaucoma and in normal individuals (with or without pseudoexfoliation syndrome). Clin Ophthalmol (2009) 0.89
Graft failure: III. Glaucoma escalation after penetrating keratoplasty. Int Ophthalmol (2008) 0.89
Comparison of anterior segment optical tomography parameters measured using a semi-automatic software to standard clinical instruments. PLoS One (2013) 0.88
Prevalence and associated factors of glaucoma in rural central India. The Central India Eye and Medical Study. PLoS One (2013) 0.87
Combination medical treatment for primary open angle glaucoma and ocular hypertension: a network meta-analysis. Cochrane Database Syst Rev (2014) 0.86
Central corneal thickness and progression of the visual field and optic disc in glaucoma. Br J Ophthalmol (2005) 0.86
[Sources of error in Goldmann applanation tonometry]. Ophthalmologe (2011) 0.85
Central corneal thickness and intraocular pressure in the Cameroonian nonglaucomatous population. Clin Ophthalmol (2010) 0.85
Randomized crossover study of latanoprost and travoprost in eyes with open-angle glaucoma. Graefes Arch Clin Exp Ophthalmol (2011) 0.85
Central corneal thickness in Japanese children. Jpn J Ophthalmol (2009) 0.84
Central corneal thickness in black Cameroonian ocular hypertensive and glaucomatous subjects. Clin Ophthalmol (2010) 0.84
Differences in central corneal thickness between the paired eyes and the severity of the glaucomatous damage. Eye (Lond) (2012) 0.84
The impact of central corneal thickness on the risk for glaucoma in a large multiethnic population. J Glaucoma (2014) 0.83
Corneal thickness as a predictor of corneal transplant outcome. Cornea (2013) 0.83
Intraocular pressure and central corneal thickness in the COMET cohort. Optom Vis Sci (2012) 0.82
Evaluation of anterior segment parameters and possible influencing factors in normal subjects using a dual Scheimpflug analyzer. PLoS One (2014) 0.82
Novel pressure-to-cornea index in glaucoma. Br J Ophthalmol (2007) 0.82
Measurement of autofluorescence in the parapapillary atrophic zone in patients with ocular hypertension. Graefes Arch Clin Exp Ophthalmol (2006) 0.82
[The risk of glaucoma and corneal thickness]. Ophthalmologe (2005) 0.81
Reliability of RTVue, Visante, and slit-lamp adapted ultrasonic pachymetry for central corneal thickness measurement. Yonsei Med J (2012) 0.81
Assessment of anterior segment parameters under photopic and scotopic conditions in Indian eyes using anterior segment optical coherence tomography. Indian J Ophthalmol (2007) 0.80
The biometric study in different stages of primary angle-closure glaucoma. Eye (Lond) (2013) 0.80
Effect of corneal astigmatism on intraocular pressure measurement using ocular response analyzer and Goldmann applanation tonometer. Graefes Arch Clin Exp Ophthalmol (2009) 0.80
Comparison of moderate and advanced glaucoma patients in Ghana. Clin Ophthalmol (2012) 0.79
The rate of structural change: the confocal scanning laser ophthalmoscopy ancillary study to the ocular hypertension treatment study. Am J Ophthalmol (2013) 0.79
Determinants of posterior corneal biometric measurements in a multi-ethnic Asian population. PLoS One (2014) 0.78
Effects of central corneal thickness, central corneal power, and axial length on intraocular pressure measurement assessed with goldmann applanation tonometry. Jpn J Ophthalmol (2008) 0.78
Measuring accurate IOPs: Does correction factor help or hurt? Clin Ophthalmol (2010) 0.78
Central and paracentral corneal pachymetry in patients with normal tension glaucoma and ocular hypertension. Graefes Arch Clin Exp Ophthalmol (2005) 0.78
Ethnic Variations in Central Corneal Thickness in a Rural Population in China: The Yunnan Minority Eye Studies. PLoS One (2015) 0.78
Intraocular pressure in Japanese diabetic patients. Clin Ophthalmol (2012) 0.77
Central corneal thickness in newly diagnosed glaucoma patients in South West Ethiopia: a cross-sectional study. BMC Ophthalmol (2016) 0.77
The impact of central corneal thickness on intraocular pressure among Ethiopian glaucoma patients: a cross-sectional study. BMC Ophthalmol (2012) 0.77
Longitudinal changes in central corneal thickness and their relation to glaucoma status: an 8 year follow up study. Br J Ophthalmol (2006) 0.77
[Results of the "Ocular hypertension treatment study"]. Ophthalmologe (2005) 0.76
Density of common complex ocular traits in the aging eye: analysis of secondary traits in genome-wide association studies. PLoS One (2008) 0.76
Central corneal thickness in southern Egypt. Int Ophthalmol (2013) 0.76
Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up. Eye (Lond) (2016) 0.75
Correlations between magnitude of refractive error and other optical components in Korean myopes. Korean J Ophthalmol (2012) 0.75
Age-related changes in central corneal thickness in normal eyes among the adult Lithuanian population. Clin Interv Aging (2014) 0.75
Relationship among Corneal Biomechanics, Anterior Segment Parameters, and Geometric Corneal Parameters. J Ophthalmol (2016) 0.75
Frequency-doubling technology perimetry and multifocal visual evoked potential in glaucoma, suspected glaucoma, and control patients. Clin Ophthalmol (2014) 0.75
Age-Related Changes in Corneal Deformation Dynamics Utilizing Scheimpflug Imaging. PLoS One (2015) 0.75
Dynamic contour tonometry in asymmetric glaucoma patients. Clin Ophthalmol (2012) 0.75
Associations with Intraocular Pressure in a Large Cohort: Results from the UK Biobank. Ophthalmology (2016) 0.75
Detecting IOP Fluctuations in Glaucoma Patients. Open Ophthalmol J (2016) 0.75
A novel method to predict visual field progression more accurately, using intraocular pressure measurements in glaucoma patients. Sci Rep (2016) 0.75
The Association of Central Corneal Thickness with Ocular and General Parameters in a Community Setting: The Yazd Eye Study. J Ophthalmic Vis Res (2017) 0.75
[Comparative measurements of central corneal thickness with two ultrasound pachymeters]. Ophthalmologe (2006) 0.75
Noninvasive measurement of wave speed of porcine cornea in ex vivo porcine eyes for various intraocular pressures. Ultrasonics (2017) 0.75
Comparison of dynamic contour tonometry and Goldmann applanation tonometry in relation to central corneal thickness in primary congenital glaucoma. Graefes Arch Clin Exp Ophthalmol (2012) 0.75
Correlation Between Dynamic Contour Tonometry, Uncorrected and Corrected Goldmann Applanation Tonometry, and Stage of Glaucoma. JAMA Ophthalmol (2017) 0.75
Influence of optic disc size on parameters of retinal nerve fiber analysis with laser scanning polarimetry. Graefes Arch Clin Exp Ophthalmol (2005) 0.75
The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol (1999) 3.30
Baseline findings in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Invest Ophthalmol Vis Sci (1998) 2.68
Compliance with topical pilocarpine treatment. Am J Ophthalmol (1986) 2.48
Clinical factors associated with progression of glaucomatous optic disc damage in treated patients. Arch Ophthalmol (2001) 2.30
Compliance with ocular therapy. Surv Ophthalmol (1980) 1.99
Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol (1986) 1.64
Confirmation of visual field abnormalities in the Ocular Hypertension Treatment Study. Ocular Hypertension Treatment Study Group. Arch Ophthalmol (2000) 1.62
Compliance with topical timolol treatment. Am J Ophthalmol (1987) 1.54
Rigid contact lens fitting relationships in keratoconus. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group. Optom Vis Sci (1999) 1.53
Biomicroscopic signs and disease severity in keratoconus. Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study Group. Cornea (1996) 1.46
Multivariate analysis of the risk of glaucomatous visual field loss. Arch Ophthalmol (1979) 1.44
Increased corneal thickness simulating elevated intraocular pressure. Arch Ophthalmol (1978) 1.40
Primary valve malfunction of the Krupin eye valve with disk. J Glaucoma (1997) 1.39
Part I. Patient administration of eyedrops: interview. Ann Ophthalmol (1982) 1.34
Prognostic significance of optic disk cupping in ocular hypertensive patients. Am J Ophthalmol (1980) 1.29
Serum free prostate specific antigen and prostate specific antigen density measurements for predicting cancer in men with prior negative prostatic biopsies. J Urol (1997) 1.24
Topical timolol administration reduces the incidence of glaucomatous damage in ocular hypertensive individuals. A randomized, double-masked, long-term clinical trial. Arch Ophthalmol (1989) 1.22
Prognostic factors in glaucomatous visual field loss. Arch Ophthalmol (1976) 1.15
Timolol maleate: efficacy and safety. Arch Ophthalmol (1979) 1.13
Systemic factors in patients with low-tension glaucoma. Br J Ophthalmol (1981) 1.12
Plasma and aqueous humor endothelin levels in primary open-angle glaucoma. J Glaucoma (1997) 1.12
The effect of a generic drug law on the retail cost of antiglaucoma medications. Am J Ophthalmol (1981) 1.11
Follow-up of angle-closure glaucoma suspects. Am J Ophthalmol (1993) 1.09
The relationship between hue discrimination and contrast sensitivity deficits in patients with diabetes mellitus. Ophthalmology (1988) 1.09
Patient administration of eyedrops: observation. Part II. Ann Ophthalmol (1982) 1.09
Comparative optic disc analysis in normal pressure glaucoma, primary open-angle glaucoma, and ocular hypertension. Ophthalmology (1996) 1.06
Contralateral effect of topical beta-adrenergic antagonists in initial one-eyed trials in the ocular hypertension treatment study. Am J Ophthalmol (2000) 1.06
Corneal scarring and vision in keratoconus: a baseline report from the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Cornea (2000) 1.05
Glaucomatocyclitic crisis and primary open-angle glaucoma. Am J Ophthalmol (1973) 1.03
Intraocular pressure the day of argon laser trabeculoplasty in primary open-angle glaucoma. Ophthalmology (1984) 1.02
Trabeculectomy with releasable sutures. Arch Ophthalmol (1994) 1.01
Postcataract ptosis. A randomized, double-masked comparison of peribulbar and retrobulbar anesthesia. Ophthalmology (1993) 1.01
Parapapillary chorioretinal atrophy in patients with ocular hypertension. I. An evaluation as a predictive factor for the development of glaucomatous damage. Arch Ophthalmol (1997) 1.00
Hormonal regulation of intraocular pressure. Surv Ophthalmol (1978) 1.00
A miniature compliance monitor for eyedrop medication. Arch Ophthalmol (1984) 0.99
Glaucomatous visual field damage. Luminance and color-contrast sensitivities. Invest Ophthalmol Vis Sci (1990) 0.98
Risk factors favoring the development of glaucomatous visual field loss in ocular hypertension. Surv Ophthalmol (1981) 0.98
Central corneal endothelial cell density and central corneal thickness in ocular hypertension and primary open-angle glaucoma. Am J Ophthalmol (1982) 0.97
Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma. Am J Ophthalmol (1988) 0.96
Histocompatibility antigens and primary open-angle glaucoma. A reassessment. Arch Ophthalmol (1978) 0.96
A dose-response study of the effect of levobunolol on ocular hypertension. Am J Ophthalmol (1983) 0.96
Steady-state pattern electroretinogram following long term unilateral administration of timolol to ocular hypertensive subjects. Doc Ophthalmol (1990) 0.96
Factors associated with corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study. Cornea (2000) 0.94
Prostaglandin and thromboxane synthesis by microsomes of rabbit ocular tissues. Invest Ophthalmol Vis Sci (1979) 0.94
Efficacy and patient acceptance of pilocarpine gel. Am J Ophthalmol (1979) 0.93
Standardized rigid contact lens fitting protocol for keratoconus. Optom Vis Sci (1996) 0.92
Timolol and epinephrine: a clinical study of ocular interactions. Arch Ophthalmol (1980) 0.91
Comparative results of combined procedures for glaucoma and cataract: II. Limbus-based versus fornix-based conjunctival flaps. Ophthalmic Surg Lasers (1997) 0.89
Compliance and prognosis in glaucoma. Arch Ophthalmol (1985) 0.89
Parapapillary chorioretinal atrophy in patients with ocular hypertension. II. An evaluation of progressive changes. Arch Ophthalmol (1997) 0.88
Long-term epinephrine therapy of ocular hypertension. Arch Ophthalmol (1976) 0.88
Quantitative visual field and optic disc correlates early in glaucoma. Arch Ophthalmol (1978) 0.88
Positive FTA-ABS tests in subjects with corticosteroid-induced uveitis. Am J Ophthalmol (1976) 0.87
Anterior lamellar sclerectomy for nanophthalmos. J Glaucoma (1992) 0.87
Prostaglandin synthesis, inhibition, and intraocular pressure. Invest Ophthalmol (1973) 0.87
Late removal of releasable sutures after trabeculectomy or combined trabeculectomy with cataract extraction supplemented with antifibrotics. J Glaucoma (1998) 0.87
Intraocular pressure and glaucoma in the Zuni indians. Arch Ophthalmol (1978) 0.86
Flurbiprofen and intraocular pressure. Ann Ophthalmol (1981) 0.86
Dipivefrin and epinephrine treatment of elevated intraocular pressure: a comparative study. Arch Ophthalmol (1979) 0.86
Comparative results of combined procedures for glaucoma and cataract: I. Extracapsular cataract extraction versus phacoemulsification and foldable versus rigid intraocular lenses. Ophthalmic Surg Lasers (1997) 0.86
Increased ocular and systemic responsiveness to epinephrine in primary open-angle glaucoma. Arch Ophthalmol (1977) 0.85
Prostaglandin E 1 and aqueous humor dynamics. Invest Ophthalmol (1972) 0.85
Anaemia in men receiving combined finasteride and flutamide therapy for advanced prostate cancer. BJU Int (1999) 0.84
Corneal scarring in the Collaborative Longitudinal Evaluation of Keratoconus (CLEK) Study: baseline prevalence and repeatability of detection. Cornea (1999) 0.84
Low-dose methazolamide and intraocular pressure. Am J Ophthalmol (1977) 0.84
Photodocumentation of corneal scarring. Collaborative Longitudinal Evaluation of Keratoconus Study Group. J Refract Surg (1996) 0.83
The dyschromatopsia of optic neuritis is determined in part by the foveal/perifoveal distribution of visual field damage. Invest Ophthalmol Vis Sci (1990) 0.83
Concordance of parapapillary chorioretinal atrophy in ocular hypertension with visual field defects that accompany glaucoma development. Ophthalmology (2000) 0.82
Retail cost of antiglaucoma drugs in two cities. Am J Ophthalmol (1978) 0.81
The pigment dispersion syndrome. Am J Ophthalmol (1977) 0.81
Trabeculectomy with releasable sutures. Trans Am Ophthalmol Soc (1993) 0.80
Retinocortical conduction time in diabetics with abnormal pattern reversal electroretinograms and visual evoked potentials. Doc Ophthalmol (1988) 0.80
Retinitis pigmentosa associated with nevus flammeus and unilateral glaucoma. Ann Ophthalmol (1977) 0.80
Histopathologic findings after Nd:YAG transscleral cyclophotocoagulation. Am J Ophthalmol (1988) 0.79
Cataract extraction in an eye with filtering bleb. Ophthalmology (1982) 0.79
Transscleral neodymium: YAG laser cyclocoagulation for uncontrolled glaucoma. Ophthalmic Surg (1990) 0.79
Increased intraocular pressure after cataract surgery. Semin Ophthalmol (1994) 0.79
The effect of topical clonidine on intraocular pressure. Arch Ophthalmol (1981) 0.79
Plasma cortisol suppression test used to predict the development of primary open-angle glaucoma. Am J Ophthalmol (1976) 0.79
MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors. Ophthalmology (1991) 0.79
Feasibility of fitting contact lenses with apical clearance in keratoconus. Optom Vis Sci (1996) 0.79
Color perimetry of glaucomatous visual field defects. Ophthalmology (1984) 0.78
Pilocarpine ocular inserts. Invest Ophthalmol (1976) 0.78
Acute intraocular pressure response to argon laser iridotomy. Ophthalmology (1985) 0.78
Chronic topical corticosteroid use simulating congenital glaucoma. J Pediatr (1972) 0.77
Intraocular pressure and visual field progression in open-angle glaucoma. Am J Ophthalmol (2000) 0.77
Repeat argon laser trabeculoplasty. Am J Ophthalmol (1987) 0.77
Timolol and epinephrine: long-term evaluation of concurrent administration. Arch Ophthalmol (1982) 0.77
Timolol plus maximum-tolerated antiglaucoma therapy. Arch Ophthalmol (1979) 0.77
Timolol plus maximum tolerated antiglaucoma therapy: a one-year followup study. Surv Ophthalmol (1979) 0.77
The effect of poor compliance and treatment side effects on sample size requirements in randomized clinical trials. J Biopharm Stat (1994) 0.77
Normal-pressure glaucoma. Am J Ophthalmol (1998) 0.77
MK-927: a topical carbonic anhydrase inhibitor. Dose response and duration of action. Arch Ophthalmol (1990) 0.77